FLI1 in PBMCs contributes to elevated inflammation in combat-related posttraumatic stress disorder.

FLI1 PBMC PTSD antisense oligonucleotides inflammation

Journal

Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006

Informations de publication

Date de publication:
2024
Historique:
received: 22 05 2024
accepted: 05 07 2024
medline: 14 8 2024
pubmed: 14 8 2024
entrez: 14 8 2024
Statut: epublish

Résumé

Post-traumatic stress disorder (PTSD) is a debilitating psychiatric condition with significant public health implications that arise following exposure to traumatic events. Recent studies highlight the involvement of immune dysregulation in PTSD, characterized by elevated inflammatory markers. However, the precise mechanisms underlying this immune imbalance remain unclear. Previous research has implicated friend leukemia virus integration 1 (FLI1), an erythroblast transformation-specific (ETS) transcription factor, in inflammatory responses in sepsis and Alzheimer's disease. Elevated FLI1 levels in peripheral blood mononuclear cells (PBMCs) have been linked to lupus severity. Yet, FLI1's role in PTSD-related inflammation remains unexplored. In our study, PBMCs were collected from Veterans with and without PTSD. We found significantly increased FLI1 expression in PBMCs from PTSD-afflicted Veterans, particularly in CD4

Identifiants

pubmed: 39140108
doi: 10.3389/fpsyt.2024.1436690
pmc: PMC11320135
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1436690

Informations de copyright

Copyright © 2024 Li, Liu, Liu, Lu, Halushka, Sidles, LaRue, Wang and Fan.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Pengfei Li (P)

Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, United States.
Research Service, Ralph H. Johnson Department of Veterans Affairs Health Care System, Charleston, SC, United States.

Liu Liu (L)

Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, United States.

Shufeng Liu (S)

Department of Psychiatry, Medical University of South Carolina, Charleston, SC, United States.

Zhongyang Lu (Z)

Department of Psychiatry, Medical University of South Carolina, Charleston, SC, United States.

Perry V Halushka (PV)

Department of Medicine, Medical University of South Carolina, Charleston, SC, United States.
Department of Pharmacology, Medical University of South Carolina, Charleston, SC, United States.

Sara J Sidles (SJ)

Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, United States.
Research Service, Ralph H. Johnson Department of Veterans Affairs Health Care System, Charleston, SC, United States.

Amanda C LaRue (AC)

Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, United States.
Research Service, Ralph H. Johnson Department of Veterans Affairs Health Care System, Charleston, SC, United States.

Zhewu Wang (Z)

Research Service, Ralph H. Johnson Department of Veterans Affairs Health Care System, Charleston, SC, United States.
Department of Psychiatry, Medical University of South Carolina, Charleston, SC, United States.

Hongkuan Fan (H)

Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, United States.

Classifications MeSH